Logotype for Divi’s Laboratories Limited

Divi’s Laboratories (DIVISLAB) investor relations material

Divi’s Laboratories Q1 25/26 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Divi’s Laboratories Limited
Q1 25/26 earnings summary6 Aug, 2025

Executive summary

  • Maintained robust global position in generics despite pricing pressures, supported by backward integration and strong customer partnerships.

  • Unit 3 facility in Kakinada operational since Jan 2025, enhancing self-sufficiency and value chain strength.

  • Custom synthesis remains a core growth engine, with a healthy pipeline of RFPs and projects expected to commercialize in 12–24 months.

  • Advanced platforms in flow chemistry, biocatalysis, and green chemistry are differentiators for global partners.

  • Significant CSR initiatives have positively impacted education and quality of life in Andhra Pradesh and Telangana.

Financial highlights

  • Consolidated total income for Q1 FY26 was ₹2,529 crore, up from ₹2,197 crore year-over-year.

  • Profit before tax for the quarter was ₹733 crore, compared to ₹604 crore in the same quarter last year.

  • Profit after tax reached ₹545 crore, up from ₹430 crore year-over-year.

  • Standalone total income was ₹2,476 crore, up from ₹2,142 crore year-over-year.

  • Forex gain for the quarter was ₹39 crore, compared to a loss of ₹1 crore last year.

Outlook and guidance

  • CapEx for FY26 estimated at ₹2,000 crore, focused on strategic projects, capacity expansion, and technology upgrades.

  • Three major CapEx programs underway, backed by long-term supply commitments.

  • New product launches expected in the next 6–12 months, pending customer approvals.

  • Custom synthesis and peptide projects expected to commercialize over the next 12–24 months, subject to regulatory approvals.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Divi’s Laboratories earnings date

Logotype for Divi’s Laboratories Limited
Q2 25/268 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Divi’s Laboratories earnings date

Logotype for Divi’s Laboratories Limited
Q2 25/268 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Divi’s Laboratories Limited manufactures active pharmaceutical ingredients (APIs), intermediates, and nutraceutical ingredients for global pharmaceutical companies. The company specializes in custom synthesis and contract manufacturing for generic and branded drugs. Divi’s Laboratories serves customers in regulated markets including the United States and Europe. The company is headquartered in Hyderabad, India, and its shares are listed on the NSE.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage